A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension
Gomberg-Maitland, M, Maitland, M L, Barst, R J, Sugeng, L, Coslet, S, Perrino, T J, Bond, L, Lacouture, M E, Archer, S L, Ratain, M J
Published in Clinical pharmacology and therapeutics (01.03.2010)
Published in Clinical pharmacology and therapeutics (01.03.2010)
Get more information
Journal Article
Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
Karovic, S, Shiuan, EF, Zhang, SQ, Cao, H, Maitland, ML
Published in Clinical and translational science (01.10.2016)
Published in Clinical and translational science (01.10.2016)
Get full text
Journal Article
A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal Dysfunction
Wu, B, Lewis, L D, Harvey, R D, Rasmussen, E, Gamelin, E, Sun, Y-N, Friberg, G, Koyner, J L, Dowlati, A, Maitland, M L
Published in Clinical pharmacology and therapeutics (01.08.2017)
Published in Clinical pharmacology and therapeutics (01.08.2017)
Get more information
Journal Article
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies
Karovic, S, Wen, Y, Karrison, T G, Bakris, G L, Levine, M R, House, L K, Wu, K, Thomeas, V, Rudek, M A, Wright, J J, Cohen, E E W, Fleming, G F, Ratain, M J, Maitland, M L
Published in Clinical pharmacology and therapeutics (01.07.2014)
Published in Clinical pharmacology and therapeutics (01.07.2014)
Get more information
Journal Article
Estimation of renal cell carcinoma treatment effects from disease progression modeling
Maitland, M L, Wu, K, Sharma, M R, Jin, Y, Kang, S P, Stadler, W M, Karrison, T G, Ratain, M J, Bies, R R
Published in Clinical pharmacology and therapeutics (01.04.2013)
Published in Clinical pharmacology and therapeutics (01.04.2013)
Get more information
Journal Article
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling
Li, CH, Bies, RR, Wang, Y, Sharma, MR, Karovic, S, Werk, L, Edelman, MJ, Miller, AA, Vokes, EE, Oto, A, Ratain, MJ, Schwartz, LH, Maitland, ML
Published in Clinical and translational science (01.02.2016)
Published in Clinical and translational science (01.02.2016)
Get full text
Journal Article
Comparative genomics analysis of human sequence variation in the UGT1A gene cluster
Maitland, M L, Grimsley, C, Kuttab-Boulos, H, Witonsky, D, Kasza, K E, Yang, L, Roe, B A, Di Rienzo, A
Published in The pharmacogenomics journal (01.01.2006)
Published in The pharmacogenomics journal (01.01.2006)
Get full text
Journal Article
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations
Rodon, J., Rodriguez, E., Maitland, M.L., Tsai, F.Y.-C., Socinski, M.A., Berlin, J.D., Thomas, J.S., Al Baghdadi, T., Wang, I.-M., Guo, C., Golmakani, M., Clark, L.N., Gazdoiu, M., Li, M., Tolcher, A.W.
Published in ESMO open (01.04.2024)
Published in ESMO open (01.04.2024)
Get full text
Journal Article
Models of excellence: improving oncology drug development
Sharma, M R, Maitland, M L, Ratain, M J
Published in Clinical pharmacology and therapeutics (01.11.2012)
Published in Clinical pharmacology and therapeutics (01.11.2012)
Get more information
Journal Article
Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non–Small-Cell Lung Cancer
Karrison, Theodore G., Maitland, Michael L., Stadler, Walter M., Ratain, Mark J.
Published in JNCI : Journal of the National Cancer Institute (03.10.2007)
Published in JNCI : Journal of the National Cancer Institute (03.10.2007)
Get full text
Journal Article
VEGF pathway therapy: Resampling positive phase III data to assess phase II trial designs and endpoints
Sharma, M., Karrison, T., Maitland, M. L., Stadler, W. M., Ratain, M. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Bayesian inference for longitudinal data with non-parametric treatment effects
Müller, Peter, Quintana, Fernando A, Rosner, Gary L, Maitland, Michael L
Published in Biostatistics (Oxford, England) (01.04.2014)
Published in Biostatistics (Oxford, England) (01.04.2014)
Get full text
Journal Article
Development of combination chemotherapy regimens: What is the yield of published phase II trials?
Hudoba, C., Maitland, M. L., Snider, K. L., Ratain, M. J.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Pharmacodynamic (PD) assessment of blood pressure (BP) in a randomized dose-ranging trial of sorafenib (S)
Maitland, M. L., Karrison, T., Bakris, G. L., Fox, K., Janisch, L. A., Karovic, S., Levine, M. R., House, L., Wright, J. J., Cohen, E. E., Fleming, G. F., Seiwert, T. Y., Villaflor, V. M., Stadler, W. M., Ratain, M. J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Fasting glucose and triglycerides as biomarkers of mTOR inhibition, evidence of a categorical response
Nallari, A. S., Karrison, T., Rosner, G. L., Levine, M. R., Sit, L., Wu, K., Stadler, W. M., Ratain, M. J., Cohen, E. E., Maitland, M. L.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Use of typical in-patient blood pressure measurements to detect bevacizumab-induced elevation in systolic pressure after the first infusion
Levine, M. R., Wroblewski, K., Dharanipragada, D., Sit, L., Karrison, T., Seiwert, T. Y., Cohen, E. E., E.okes, E., Maitland, M. L.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Effects of vascular endothelial growth factor (VEGF) signaling inhibition on human erythropoiesis
Maitland, M. L., Kasza, K. E., Snider, K. L., Sit, L., Cohen, E. E., Seiwert, T. Y., Karrison, T., Ratain, M. J., Vokes, E. E.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A genotype-directed phase I study of irinotecan in advanced cancer patients
Innocenti, F., Janisch, L., Das, S., Ramirez, J., House, L., Maitland, M. L., Salgia, R., Ratain, M. J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Refining epidermal growth factor receptor (EGFR) -inhibition-related rash (EIRR) phenotypes with a cetuximab (C) monotherapy stage of a phase II trial for non-small cell lung cancer (NSCLC)
Maitland, M. L., Kasza, K. E., Lacouture, M. E., Liu, W., Soltani, K., Kozloff, M. F., Hoffman, P. C., Salgia, R., Karrison, T., Vokes, E. E.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article